Literature DB >> 12692774

Cigarette-derived nicotine is not a medicine.

Andrew C Parrott1.   

Abstract

Regular smokers feel better when smoking than not smoking, and empirical studies confirm that nicotine reinstatement relieves feelings of stress, depression and anger. These acute mood changes have led to the belief that cigarette-derived nicotine can provide medicinal benefits for smokers. However, prospective studies of adolescents who take up cigarette smoking find that they report increased levels of anxiety, stress and depression. Furthermore, adults who quit smoking report enduring mood improvements. Thus the prospective data shows that the nicotine derived from cigarettes leads to heightened distress. The empirical patterns of mood change reported by regular smokers show why nicotine dependency is psychologically damaging. Regular smokers report average moods when replete with nicotine, but suffer mood deteriorations in-between cigarettes. Thus the supposed mood gains of smoking only represent the temporary relief of withdrawal symptoms. This mood relief becomes conditioned with smoke inhalation, which is why cigarettes are regarded positively by smokers. However, the repetitive experience of irritability and other abstinence symptoms in between cigarettes paradoxically causes smokers to suffer worse daily moods than non-smokers. The stronger the nicotine dependency the greater the mood decrements, helping to explain why disadvantaged individuals often smoke heavily and find quitting difficult. In conclusion, there is no empirical evidence that cigarettes provide medicinal benefits, but extensive data showing that nicotine dependency heightens psychological distress in tobacco smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692774     DOI: 10.3109/15622970309167951

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  32 in total

1.  Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt.

Authors:  Megan E Piper; Susan Kenford; Michael C Fiore; Timothy B Baker
Journal:  Ann Behav Med       Date:  2012-04

Review 2.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

3.  The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey.

Authors:  Jae Cooper; Ron Borland; Hua-Hie Yong; Omid Fotuhi
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

4.  Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Authors:  Serena Tonstad; Simon Davies; Martina Flammer; Cristina Russ; John Hughes
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

5.  Longitudinal Investigation of Smoking Initiation and Relapse Among Younger and Older US Military Personnel.

Authors:  Edward J Boyko; Daniel W Trone; Arthur V Peterson; Isabel G Jacobson; Alyson J Littman; Charles Maynard; Amber D Seelig; Nancy F Crum-Cianflone; Jonathan B Bricker
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

6.  Suicidality prospectively predicts greater urges to smoke following a cessation attempt: Mediation through perceived barriers to cessation.

Authors:  Brian J Albanese; Nicholas P Allan; Joseph W Boffa; Jesus Chavarria; Amanda M Raines; Michael J Zvolensky; Norman B Schmidt
Journal:  J Affect Disord       Date:  2015-10-21       Impact factor: 4.839

7.  Tobacco smoke containing high or low levels of nicotine during adolescence: effects on novelty-seeking and anxiety-like behaviors in mice.

Authors:  Yael Abreu-Villaça; Cláudio C Filgueiras; Monique Correa-Santos; Cristiane C Cavina; Victor F Naiff; Thomas E Krahe; Alex C Manhães; Anderson Ribeiro-Carvalho
Journal:  Psychopharmacology (Berl)       Date:  2014-11-18       Impact factor: 4.530

Review 8.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

Review 9.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

Review 10.  Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

Authors:  Lauren C Smith; Olivier George
Journal:  Neuropharmacology       Date:  2020-08-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.